BERTONI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 9.288
EU - Europa 5.462
AS - Asia 5.007
SA - Sud America 748
AF - Africa 287
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 4
Totale 20.813
Nazione #
US - Stati Uniti d'America 9.060
SG - Singapore 2.004
CN - Cina 1.824
FI - Finlandia 972
IT - Italia 926
IE - Irlanda 804
SE - Svezia 779
BR - Brasile 611
DE - Germania 571
UA - Ucraina 456
HK - Hong Kong 378
VN - Vietnam 287
NL - Olanda 233
GB - Regno Unito 215
TR - Turchia 179
ZA - Sudafrica 175
CA - Canada 150
IN - India 113
RU - Federazione Russa 111
FR - Francia 93
BE - Belgio 73
CI - Costa d'Avorio 65
AR - Argentina 56
BD - Bangladesh 49
AT - Austria 47
MX - Messico 44
CZ - Repubblica Ceca 41
ES - Italia 35
PL - Polonia 28
JP - Giappone 24
EC - Ecuador 21
KR - Corea 21
ID - Indonesia 19
IQ - Iraq 19
RO - Romania 19
CO - Colombia 17
EU - Europa 17
PK - Pakistan 15
LT - Lituania 14
VE - Venezuela 12
MA - Marocco 11
PY - Paraguay 10
EG - Egitto 9
IR - Iran 9
PA - Panama 9
AE - Emirati Arabi Uniti 7
KE - Kenya 7
MY - Malesia 7
BO - Bolivia 6
CR - Costa Rica 6
HU - Ungheria 6
JM - Giamaica 6
NP - Nepal 6
AZ - Azerbaigian 5
BY - Bielorussia 5
PE - Perù 5
TH - Thailandia 5
TN - Tunisia 5
UY - Uruguay 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CL - Cile 4
DK - Danimarca 4
PH - Filippine 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
MD - Moldavia 3
OM - Oman 3
PT - Portogallo 3
SA - Arabia Saudita 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
AU - Australia 2
BN - Brunei Darussalam 2
CM - Camerun 2
ET - Etiopia 2
LB - Libano 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
KH - Cambogia 1
Totale 20.809
Città #
Dallas 2.929
Singapore 1.038
Dublin 803
Chandler 790
Ashburn 781
Santa Clara 497
Jacksonville 493
Beijing 456
Ann Arbor 383
Dearborn 376
Hong Kong 374
Parma 297
Boardman 275
New York 190
Nanjing 185
Munich 175
Johannesburg 168
Shanghai 155
Izmir 152
Princeton 138
Ho Chi Minh City 123
Los Angeles 117
Wilmington 107
Hefei 91
San Mateo 90
Helsinki 81
Toronto 80
Abidjan 65
Brussels 65
Hebei 64
Nanchang 62
São Paulo 62
Kunming 60
Bremen 55
Guangzhou 54
Jinan 54
Hanoi 53
Moscow 53
Buffalo 50
Shenyang 50
Woodbridge 44
Changsha 43
Chicago 40
Bologna 39
Seattle 39
London 37
Des Moines 36
Vienna 36
Groningen 33
Tianjin 33
Frankfurt am Main 30
Milan 30
Turku 30
Columbus 29
Montreal 29
Bangalore 27
Brooklyn 27
Grafing 27
Marseille 27
Auburn Hills 24
Fremont 24
Norwalk 24
Amsterdam 23
Brno 23
Tokyo 22
Council Bluffs 21
Hangzhou 21
Houston 21
Jiaxing 21
Reggio Emilia 21
Rio de Janeiro 21
Warsaw 20
Zhengzhou 19
Nuremberg 17
Orem 17
Stockholm 16
Belo Horizonte 15
Brescia 15
Chennai 15
Manchester 15
Pune 15
Atlanta 14
Boston 14
Curitiba 14
Redondo Beach 14
Rome 14
Denver 13
Haiphong 13
Jakarta 13
Mexico City 13
Ottawa 13
Phoenix 13
Seoul 13
The Dalles 13
West Jordan 13
Düsseldorf 12
Modena 12
Lubbock 11
Poplar 11
Dhaka 10
Totale 13.400
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.634
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.588
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 228
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 209
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 208
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 189
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 186
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 178
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 174
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 171
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 170
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 163
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach 163
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 160
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 160
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 158
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 158
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 157
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 157
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 156
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 154
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 153
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 150
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 149
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 148
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 148
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 148
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 147
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 147
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 146
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 146
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 145
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 143
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 141
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 141
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 140
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 139
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 139
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 138
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 138
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 137
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 136
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 135
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 134
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 133
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 132
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 132
Analgesic activity of new hybrid muscarinic agonists in mice 132
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 130
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 130
Motor responses of rat hypertrophic intestine following chronic obstruction 130
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 130
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 128
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 128
CNS access of selected H3-antagonists: ex vivo binding study in rats 126
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 126
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 125
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 125
Influence of Nitric Oxide system in mesenteric ischemia-reperfusion induced injury in mice 125
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 124
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 124
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 123
Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats 123
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 123
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 121
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 121
Up-regulation of inhibitory transmitters in myenteric neurons of the rat ileum in an acute model of ischemia/reperfusion 121
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 121
PHARMACOLOGICAL CHARACTERIZATION OF NEW COMPOUNDS AIMED AT INHIBITING EPH-EPHRIN INTERACTION IN GLIOBLASTOMA 120
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 120
Influence of gender in the mesenteric ischemia/reperfusion model in mice 120
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 119
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 117
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 117
RESPONSIVENESS OF LONGITUDINAL AND CIRCULAR MUSCLE TO RELAXING MEDIATORS IS DIFFERENTIALLY AFFECTED IN RAT HYPERTROPHIED ILEUM 116
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 116
Evidence for the involvement of 5-HT(2A) receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice 115
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 115
Role of Glutamate- N-methyl-D-Aspartate (NMDA) Receptors in Neuronal Plasticity and Gastrointestinal Transit Delay Induced by Ischemia/Reperfusion in Rats 115
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 115
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 115
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 114
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 114
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 114
Heterogeneous response of colonoid-derived monolayers to TNFa and IFNg exposure: functional and morphological characterization 113
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 113
The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice 113
Glutamate receptor activation mediates the effects of ischemia/reperfusion on gastrointestinal transit and neuronal phenotypes in the rat myenteric plexus 113
Protection by the EPH-EPHRIN System Against Mesenteric Ischemia-Reperfusion Injury 112
Benzofuran-2-Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20-Induced Chemotaxis and Colon Cancer Growth 108
Allosteric Modulation of Muscarinic Acetylcholine-Receptors: Oxotremorine-Phthalimidoalkyl-Hybrids of the Hexamethonio-type 108
Involvement of 5-HT2A receptors in motor and inflammatory disorders induced by mesenteric ischemia reperfusion in mice 107
PHENYLPROPANOID RICH ESSENTIAL OILS AS POTENTIAL ANTITHROMBOTICS ENDOWED WITH GASTROPROTECTIVE EFFECTS 107
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 106
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 106
Synthesis and functional characterization of novel heterocyclic derivatives related to oxotremorine and oxotremorine-M 105
New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes 105
Interactions of new and conventional H3-blockers with non-histaminergic receptors involved in neurogenic and myogenic contractile responses of guinea-pig ileum 105
Functional plasticity of rat intestine after removal of chronic mechanical obstruction 102
Functional study of the central access of chemical delivery systems developed as g-aminobutyric acid (GABA) prodrugs 102
Totale 16.429
Categoria #
all - tutte 65.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021607 0 0 0 0 0 41 130 28 201 43 140 24
2021/2022836 32 23 32 91 51 56 94 104 33 58 58 204
2022/20233.138 347 320 181 234 320 344 67 174 932 45 121 53
2023/20241.227 69 80 46 47 88 313 126 84 38 66 97 173
2024/20253.732 137 193 260 237 383 430 157 168 398 367 271 731
2025/20267.028 842 1.238 2.826 796 1.127 199 0 0 0 0 0 0
Totale 20.981